DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Thyro-block is a drug marketed by Meda Pharms and is included in one NDA.
The generic ingredient in THYRO-BLOCK is potassium iodide. There are two hundred and forty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
A generic version of THYRO-BLOCK was approved as potassium iodide by MISSION PHARMACAL CO on March 24th, 2016.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Meda Pharms||THYRO-BLOCK||potassium iodide||TABLET;ORAL||018307-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|